Funding fuels Dreem Health’s nationwide expansion, tackling America’s critical shortage of sleep doctors

Sunrise Group, a leader in sleep health technology, today announced a $29 million funding round to expand Dreem Health, its digital sleep clinic, across all 50 states. The round was led by Eurazeo, with participation from Amazon’s Alexa Fund, WE International, Kurma Partners, Vives Fund, Majycc (an UI Investissement fund), Namur Invest, Seventure Partners, Investsud, Sambrinvest, Noshaq, IMBC and Invest.BW.

More than 70 million Americans live with sleep disorders, yet there is only one sleep doctor for every 43,000 people — the equivalent of a sold-out Citi Field depending on a single physician. This shortage leaves millions waiting for care or going untreated, while preventable sleep issues quietly drive up healthcare costs and chronic disease.

​​Dreem Health is addressing this crisis by making expert sleep care accessible from home. Patients connect directly with licensed sleep specialists, who diagnose and treat the full spectrum of sleep disorders — from sleep apnea to insomnia — all from home, with care covered by insurance. This model is powered by Sunrise’s proprietary technology, including its FDA-cleared mandibular sensor for accurate, at-home diagnosis of sleep apnea. These developments strengthen Sunrise’s unique position as both a technology innovator with proprietary medical devices and a care provider with a digital-first patient experience.

With the new funding, Sunrise Group will accelerate Dreem Health’s nationwide growth, expand clinical services, and invest in the next generation of sleep technology. That means building advanced hardware and software to improve how sleep disorders are detected, monitored, and treated. The company’s goal is simple: to make sleep care faster, easier, and available to anyone, anywhere.

“We have more sleep data than ever before — from smartwatches to connected mattresses — but sleep quality hasn’t kept pace,” said Laurent Martinot, CEO and Founder of Sunrise Group. “Trackers alone can’t solve the problem. Real progress happens when technology connects with care. Because the future of sleep care isn’t another app, or another device — it’s a connected pathway. And that’s where Sunrise and Dreem Health are stepping up.”

Sunrise Group has already built a strong foundation for scale. The company is providing services in all 50 states, with regulatory clearances secured nationwide and contracts with major payors covering more than 170 million patients. Dreem Health’s rapid expansion is supported by a team of over 80 people — licensed sleep specialists, care providers, engineers, technicians, and researchers — and a network of more than 500 referring providers. Recent partnerships and collaborations further strengthen this model, making it possible to treat the full spectrum of sleep disorders in one place.

“What sets Sunrise Group apart is the combination of hardware and software built specifically for sleep health — technology that directly powers Dreem Health’s clinical services,” said Maxime Huerre, VP Venture at Eurazeo. “It’s not just another app or device. It’s the backbone of a new, scalable model for how sleep care will be delivered.”

About Sunrise Group

Founded in 2015, Sunrise Group® is a pioneer in sleep health technology. The company first developed an FDA-cleared mandibular movement sensor, a lightweight at-home diagnostic device for sleep apnea that has been validated in peer-reviewed studies and endorsed by leading sleep experts. Today, Sunrise builds on that breakthrough to develop advanced hardware and software to detect, monitor, and treat sleep disorders, and brings this expertise to Dreem Health®, its U.S. digital sleep clinic. Headquartered in Belgium with offices in France and the United States, the team brings together leaders in sleep research, patient care, and medical technology.

Learn more at us.hellosunrise.com and dreemhealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250925606541/en/